Cite
USE OF CARDIOVASCULAR RISK REDUCTION THERAPIES IN PATIENTS WITH TYPE 2 DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE — THE HOUSTON METHODIST HOSPITAL.
MLA
Taha, Mohamad B., et al. “Use of Cardiovascular Risk Reduction Therapies in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease — the Houston Methodist Hospital.” Journal of the American College of Cardiology (JACC), vol. 81, Mar. 2023, p. 1775. EBSCOhost, https://doi.org/10.1016/S0735-1097(23)02219-2.
APA
Taha, M. B., Bose, B., Lahan, S., Khan, S., Sharma, G., Soliman, A., Bhimaraj, A., Patel, K., Cainzos-Achirica, M., & Nasir, K. (2023). Use of Cardiovascular Risk Reduction Therapies in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease — the Houston Methodist Hospital. Journal of the American College of Cardiology (JACC), 81, 1775. https://doi.org/10.1016/S0735-1097(23)02219-2
Chicago
Taha, Mohamad B., Budhaditya Bose, Shubham Lahan, Safi Khan, Garima Sharma, Ahmed Soliman, Arvind Bhimaraj, Kershaw Patel, Miguel Cainzos-Achirica, and Khurram Nasir. 2023. “Use of Cardiovascular Risk Reduction Therapies in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease — the Houston Methodist Hospital.” Journal of the American College of Cardiology (JACC) 81 (March): 1775. doi:10.1016/S0735-1097(23)02219-2.